These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2673747)

  • 1. Hyperreninemia and hypertension observed during Kaufmann therapy of patients with gonadal dysgenesis and hypopituitarism.
    Okada Y; Ogihara T
    Endocrinol Jpn; 1989 Apr; 36(2):211-8. PubMed ID: 2673747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatomedin-C levels in children and adolescents with gonadal dysgenesis: differences from age-matched normal females and effect of chronic estrogen replacement therapy.
    Cuttler L; Van Vliet G; Conte FA; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1087-92. PubMed ID: 4039732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The mixed gonadal dysgenesis. Diagnostic criteria and surgical treatment].
    Blanco JA; Martínez-Mora J; Granada M; Toran N; Isnard RM; Castellví A; Casasa JM
    Cir Pediatr; 1997 Jan; 10(1):34-7. PubMed ID: 9131963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial response to estrogen and progesterone therapy in patients with gonadal dysgenesis.
    Benjamin I; Block RE
    Obstet Gynecol; 1977 Aug; 50(2):136-8. PubMed ID: 876552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial 46,XX gonadal dysgenesis.
    Portuondo JA; Neyro JL; Benito JA; de los Rios A; Barral A
    Int J Fertil; 1987; 32(1):56-8. PubMed ID: 2880817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol and progesterone receptor concentrations and 17 beta-hydroxysteroid-dehydrogenase activity in estrogen-progestin stimulated endometrium of women with gonadal dysgenesis.
    Lübbert H; Pollow K; Römmler A; Hammerstein J
    J Steroid Biochem; 1982 Aug; 17(2):143-8. PubMed ID: 6810024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen therapy for gonadal dysgenesis: a rational approach.
    Katayama KP; Mattingly RF
    Endocrinol Jpn; 1983 Apr; 30(2):205-9. PubMed ID: 6641641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal and cytogenetic studies in phenotypically female patients with gonadal dysgenesis.
    Muechler EK; Cary D; Friedrich MA; Doherty RA; Donaldson CH; Bonfiglio T
    Int J Gynaecol Obstet; 1981 Apr; 19(2):109-18. PubMed ID: 6119241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormonal and cytogenetic parallel in gonadal dysgenesis].
    Maleeva A
    Akush Ginekol (Sofiia); 1979; 18(5):350-8. PubMed ID: 117719
    [No Abstract]   [Full Text] [Related]  

  • 10. Two cases of 17 alpha-hydroxylase deficiency--one combined with complete gonadal agenesis.
    Tvedegaard E; Frederiksen V; Olgaard K; Nielsen MD; Starup J
    Acta Endocrinol (Copenh); 1981 Oct; 98(2):267-73. PubMed ID: 6270940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral contraceptives and hypertension].
    Werning C; Siegenthaler W
    Schweiz Med Wochenschr; 1971 Apr; 101(15):543-4. PubMed ID: 4325189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal estradiol substitution therapy for the induction of puberty in female hypogonadism.
    Cisternino M; Nahoul K; Bozzola M; Grignani G; Perani G; Sampaolo P; Roger M; Severi F
    J Endocrinol Invest; 1991 Jun; 14(6):481-8. PubMed ID: 1774444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GONADAL DYSGENESIS AND HYPOPITUITARISM (DELETION-INDUCED HEMIZYGOSITY).
    BECKER KL; ALBERT A; PARIS J
    Proc Staff Meet Mayo Clin; 1963 Oct; 38():467-75. PubMed ID: 14053737
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of hormonal levels of LH and FSH with cytogenetic findings in patients with gonadal dysgenesis].
    Santavý J; Fingerová H; Knopová V; Fargasová I; Zenísek L
    Bratisl Lek Listy; 1985 May; 83(5):485-92. PubMed ID: 3928097
    [No Abstract]   [Full Text] [Related]  

  • 16. [Syndrome of transverse medullary lesion after injection of an estro-progestinic preparation].
    Sepe Visconti O; Valiani R; Fasanaro AM; Brandonisio A
    Acta Neurol Quad (Napoli); 1978; 37():67-71. PubMed ID: 576114
    [No Abstract]   [Full Text] [Related]  

  • 17. [Elevated prolactin reserves in gonadal dysgenesis and agonadism].
    Stögmann W; Frey E; Frisch H; Herkner K
    Helv Paediatr Acta; 1983 Oct; 38(4):315-21. PubMed ID: 6654681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancies following ovum donation in gonadal dysgenesis.
    Cornet D; Alvarez S; Antoine JM; Tibi C; Mandelbaum J; Plachot M; Salat-Baroux J
    Hum Reprod; 1990 Apr; 5(3):291-3. PubMed ID: 2351712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormone findings in women with gonadal dysgenesis].
    Kobilková J; Stárka L; Hampl R; Musilová J; Raboch J; Raboch J; Putz Z
    Cesk Gynekol; 1987 Mar; 52(2):110-5. PubMed ID: 3581193
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypopituitarism and gonadal dysgenesis; the relation of the pituitary gland to sexual differentiation.
    HOFFENBERG R; JACKSON WP
    Lancet; 1956 Dec; 271(6955):1237-9. PubMed ID: 13386216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.